Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 226 |
|
|||||
| News | - | ||||||
| Day High | 4.48 | Low High |
|||||
| Day Low | 4.3901 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Edesa Biotech Inc | EDSA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0529 | -1.19% | 4.3901 | 10:11:32 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.48 | 4.3901 | 4.48 | 4.443 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10 | 226 | US$ 4.39 | US$ 992 | - | 2.4603 - 8.61 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:58:20 | 5 | US$ 4.5469 | USD |
Edesa Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 13.92M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Edesa Biotech News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/01/2024 | 17:20 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/09/2024 | 15:46 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2/09/2024 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/02/2024 | 20:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/29/2024 | 15:29 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 1/16/2024 | 16:03 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 1/12/2024 | 16:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/15/2023 | 15:44 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 12/15/2023 | 15:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/26/2023 | 07:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/23/2023 | 06:58 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/12/2023 | 11:22 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EDSA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.49 | 4.88 | 4.26 | 4.38 | 3,017 | -0.0999 | -2.22% |
| 1 Month | 4.35 | 4.9566 | 4.12 | 4.50 | 4,871 | 0.0401 | 0.92% |
| 3 Months | 5.20 | 5.99 | 3.88 | 4.81 | 11,142 | -0.8099 | -15.58% |
| 6 Months | 3.22 | 6.46 | 2.50 | 4.46 | 20,703 | 1.17 | 36.34% |
| 1 Year | 8.05 | 8.61 | 2.4603 | 5.10 | 61,362 | -3.66 | -45.46% |
| 3 Years | 39.62 | 84.00 | 2.4603 | 58.50 | 395,683 | -35.23 | -88.92% |
| 5 Years | 36.05 | 133.70 | 2.4603 | 54.07 | 409,941 | -31.66 | -87.82% |
Edesa Biotech Description
| Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients. |
